Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study.

By A. Cohen, V. Tapson, J. Bergmann, Samuel Z. Goldhaber, A. Kakkar, B. Deslandes, Wei Huang, M. Zayaruzny, Leigh A. Emery, F. Anderson. The Lancet, 2008

1,443 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Internal Medicine

View Paper: https://www.semanticscholar.org/paper/cf6c1e1750316c1f4e528bd41bfa55eacc3b5131

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. K. Bauer
2. G. Agnelli

In Internal Medicine

1. M. Cushman
2. K. Bauer
3. G. Agnelli
4. S. Konstantinides

Citations in the corpus

• Thrombosis: A major contributor to global disease burden (2014, neutral): “However, a global audit of utilisation of primary thromboprophylaxis documented widespread underuse in eligible patients (89).”
• Thrombosis: A Major Contributor to Global Disease Burden (2014, neutral): “of primary thromboprophylaxis documented widespread underuse in eligible patients.(89) There is evidence that a concerted effort”
• American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients. (2018, result): “This may be due, in part, to (1) shorter lengths of stay and truncated thromboprophylaxis regimens compared with older studies that showed significant reductions in thromboembolic events with prophylaxis or insufficient duration of follow-up in research studies(28-30); (2) overprophylaxis of low-ris”
• Guidelines on the Diagnosis and Management of Acute Pulmonary Embolism (2008, background): “5% patients at risk of VTE due to medical or surgical causes, respectively, received adequate prophylaxis.(21) An association between idiopathic PE and cardiovascular events,”